CARMAT | ALCAR Logo | Annual Report & Investor Relations Data

CARMAT | ALCAR Annual Report & Investor Relations Data

ISIN

FR0010907956

Ticker

ALCAR

Sector

Health Care

Industry

Health Care Equipment & Supplies

Country

France

Year Founded

2008

CARMAT (ALCAR)
Company Overview & Profile

Company Description

CARMAT is a French MedTech that designs, manufactures and markets the Aeson® artificial heart. The Company’s ambition is to make Aeson® the first alternative to a heart transplant, and thus provide a therapeutic solution to people suffering from end-stage biventricular heart failure, who are facing a well-known shortfall in available human grafts.

The world’s first physiological artificial heart that is highly hemocompatible, pulsatile and self-regulated, Aeson® could save, every year, the lives of thousands of patients waiting for a heart transplant. The device offers patients quality of life and mobility thanks to its ergonomic and portable external power supply system that is continuously connected to the implanted prosthesis. Aeson® is commercially available as a bridge to transplant in the European Union and other countries that recognize CE marking. Aeson® is also currently being assessed within the framework of an Early Feasibility Study (EFS) in the United States.

Served Area

Worldwide

Headquarters

Immeuble l'Etendard 36 Avenue de l'Europe
78141, Vélizy-Villacoublay Cedex
France

CARMAT (ALCAR)
Filings & Annual Reports

Filters

View all types
Type Document Details Language Filing Date File Number

Get API Access

Access comprehensive European stock market filings data through a single, powerful API.

1,5M+

filings covered

18

European countries

30min

max latency

1 API

for all filings

CARMAT (ALCAR)
Insider Trading Activity

Date Trading entity / Person Association Trade type Volume
29.01.2024 None Other Other EUR 1,499,996.61
29.01.2024 None Other Other EUR 249,997.44
23.10.2023 None Other Other EUR 6,999,991.20
23.10.2023 None Other Other EUR 3,749,997.60
23.10.2023 None Other Other EUR 499,996.80
19.10.2023 None Other Sell EUR 33,200.00
15.10.2023 None Other Other EUR 3,749,997.60

CARMAT (ALCAR)
Leadership: Management & Supervisory Board

No Leadership Information Available

We currently don't have information about the management or supervisory board for this company. This information will be updated as soon as it becomes available.

CARMAT (ALCAR)
Stock & Investor Information

ISIN

FR0010907956

LEI

969500ARXACM0P0KH333

Stock Exchange Listings

Euronext Paris

Primary Stock Exchange Listing

View CARMAT on main stock exchange

CARMAT (ALCAR)
Related Companies & Peer Group

Achiko AG Logo

Achiko AG

ACHI

Sector

Health Care

Country

Switzerland

ISIN

CH0522213468

Founded

Achiko AG (SIX: ACHI.SW; OTCQB: ACHKF; www.achiko.com) is developing disruptive diagnostic solutions that puts people first. The company’s lead product …

Affluent Medical Logo

Affluent Medical

AFME

Sector

Health Care

Country

France

ISIN

FR0013333077

Founded

2011

ffluent Medical is committed to offering the best available therapies worldwide for hitherto largely unmet needs in terms of widespread …

Airway Medix S.A. Logo

Airway Medix S.A.

AWM

Sector

Health Care

Country

Poland

ISIN

PLAIRWY00017

Founded

2013

Airway Medix S.A. focuses on research and development work and commercialisation of innovative, disposable devices for the mechanically ventilated patients …

Alcon AG Logo

Alcon AG

ALC

Sector

Health Care

Country

Switzerland

ISIN

CH0432492467

Founded

1945

Alcon is the global leader in eye care, dedicated to helping people see brilliantly. With our 70-plus-year heritage, we are …

Ambu Logo

Ambu

AMBU

Sector

Health Care

Country

Denmark

ISIN

DK0060946788

Founded

1937

Ambu has been bringing the solutions of the future to life since 1937. Today, millions of patients and healthcare professionals …

Bactiguard Holding Logo

Bactiguard Holding

BACTI

Sector

Health Care

Country

Sweden

ISIN

SE0005878741

Founded

2005

Bactiguard is a Swedish medical device company with a mission to save lives. To achieve this mission, we develop and …